ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

The alleviating effect of Scutellaria amoena extract on the regulation of gut microbiota and its metabolites in NASH rats by inhibiting the NLRP3/ASC/caspase-1 axis

Lin, Yu-Ping; Fang, Qiong-Lian; Fu, Sheng-Nan; Li, Xin-Ping; Shi, Rui; Du, Cheng-Hong; Qiao, Xue; Yin, Xun-Qing; Zeng, Yong-Cheng; Zhao, Xiu-Juan; Hua, Yan*云南大学; y
Frontiers in Pharmacology2023-11-7DOI: 10.3389/fphar.2023.1143785
7阅读
引用收藏
分享

摘要

Background: Scutellaria amoena (SA) is the root of S. amoena C.H. Wright of Labiatae, also known as Scutellaria southwestern. This is mainly distributed in Sichuan, Yunnan, and Guizhou in China. In southwest China, SA is used as an alternative method to genuine medicine for the treatment of allergy, diarrhea, inflammation, hepatitis, and bronchitis. Thus far, studies on the effects of SA on non-alcoholic steatohepatitis (NASH) are lacking. This paper investigated the effect of SA on the regulation of gut microbiota and its metabolites in NASH rats by inhibiting the NOD-like receptor 3 (NLRP3)/apoptosis-associated speck-like protein (ASC)/caspase-1 axis.Methods: A NASH rat model was induced by a high-fat diet (HFD) for 12 weeks, and rats were orally given different doses of SA extracts (150 and 300 mg/kg/d) for 6 weeks. Changes in histological parameters, body weight, organ indexes, cytokines, and biochemical parameters related to NLRP3 in NASH rats were checked. 16S rRNA gene sequencing and UPLC-MS/MS technology were used to analyze the changes in the gut microbiota composition and its metabolites in NASH rats.Results: SA significantly inhibited the HFD-induced increase in body weight, lipid levels, and inflammatory infiltration. SA notably inhibited the HFD-induced increase in the upper and lower factors of NLRP3, such as transforming growth factor (TGF)-beta, tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, IL-18, pro-IL-18, IL-1 beta, pro-IL-1 beta, NLRP3, ASC, and caspase-1. Additionally, mRNA expressions of caspase-1, NLRP3, and ASC were significantly downregulated after SA treatment. The results of the intestinal flora showed that SA could increase the diversity of flora and change its structure and composition in NASH rats by reducing Firmicutes/Bacteroidetes (F/B) ratio, Blautia (genus), Lachospiraceae (family), and Christensenellaceae R-7 group (genus), and increasing Muribaculaceae (family) and Bacteroides (genus). The metabolomics revealed that 24 metabolites were possibly the key metabolites for SA to regulate the metabolic balance of NASH rats, including chenodeoxycholic acid, xanthine, and 9-OxoODE. Nine metabolic pathways were identified, including primary bile acid biosynthesis, bile secretion, purine metabolism, and secondary bile acid biosynthesis.Conclusion: SA can regulate the intestinal microbial balance and metabolic disorder by inhibiting the NLRP3/ASC/caspase-1 axis to relieve NASH.

学科与关键词

关键词
Scutellaria amoenaNASHNLRP3/ASC/caspase-1 axisgut microbiotametabolites
相关
加载中…
  • Effects of Tylophora yunnanensis Schltr on regulating the gut microbiota and its metabolites in non-alcoholic steatohepatitis rats by inhibiting the activation of NOD-like receptor protein 3
    Lin, Yu-ping; Fang, Qiong-lian; Xue, Yong-mei; Fu, Sheng-nan; Hu, Chun-Yan; Huang, Feng; Wang, Meng-meng; Qiao, Xue; Yin, Xun-qing; Zeng, Yong-cheng; Du, Cheng-hong; Zhao, Xiu-juan; Li, Xin-ping*; Hua, Yan*Journal of Ethnopharmacology, 2023, 305: 116145.被引 4
  • Flavonoids from Scutellaria amoena C. H. Wright alleviate mitochondrial dysfunction and regulate oxidative stress via Keap1/Nrf2/HO-1 axis in rats with high-fat diet-induced nonalcoholic steatohepatitis
    Fang, Qiong-Lian; Qiao, Xue; Yin, Xun-qing; Zeng, Yong-cheng; Du, Cheng-hong; Xue, Yong-mei; Zhao, Xiu-juan; Hu, Chun-yan; Huang, Feng*; Lin, Yu -ping*Biomedicine and Pharmacotherapy, 2023, 158: 114160.被引 3
  • Salvianolic acid B ameliorates non-alcoholic fatty liver disease by inhibiting hepatic lipid accumulation and NLRP3 inflammasome in ob/ob mice
    Meng, Ling-Cui; Zheng, Jia-Yi; Qiu, Yu-Hui; Zheng, Li; Zheng, Jue-Yan; Liu, Yu-Qing; Miao, Xiao-Lu*; Lu, Xin-Yi*International Immunopharmacology, 2022, 111: 109099.被引 9
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Pharmacology
发表日期
2023-11-07
卷期
第 14 卷
页码
1143785
DOI
10.3389/fphar.2023.1143785
语言
ENGLISH
成果收录
SCIE
资助标注
This work was financially supported by the National Key R and D Program of China (2021YFD1000202), the National Natural Science Foundation of China (82160781), the Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Fun [2021YFD1000202]; National Key R and D Program of China [82160781]; National Natural Science Foundation of China [2017FF117 (-022), 202001AZ070001-042]; Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Yunnan University of Chinese Medicine

作者

  • L

    Lin, Yu-Ping (第一作者)

    yunnan univ · southwest forestry univ

  • F

    Fang, Qiong-Lian

    yunnan univ

查看全部 11 位作者收起作者
  • F

    Fu, Sheng-Nan

    yunnan univ

  • L

    Li, Xin-Ping

    yunnan univ

  • S

    Shi, Rui

    southwest forestry univ

  • D

    Du, Cheng-Hong

    yunnan univ

  • Q

    Qiao, Xue

    yunnan univ

  • Y

    Yin, Xun-Qing

    yunnan univ

  • Z

    Zeng, Yong-Cheng

    yunnan univ

  • Z

    Zhao, Xiu-Juan

    yunnan univ

  • H

    Hua, Yan (通讯)

    southwest forestry univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417